SPECT/CT in pediatric patient management

Hybrid SPECT/CT imaging is becoming the standard of care in pediatric imaging. Indications are mainly for oncologic imaging including mIBG scintigraphy for neuroblastoma and I-123 post surgical imaging of children with thyroid carcinoma, bone scintigraphy for back pain, children referred from sports...

Full description

Saved in:
Bibliographic Details
Published in:European journal of nuclear medicine and molecular imaging 2014-05, Vol.41 (Suppl 1), p.104-114
Main Author: Nadel, Helen R.
Format: Article
Language:English
Subjects:
Cardiology
Congenital Abnormalities - diagnostic imaging
Humans
Imaging
Medicine
Medicine & Public Health
Multimodal Imaging
Musculoskeletal Diseases - diagnostic imaging
Neoplasms - diagnostic imaging
Nuclear Medicine
Oncology
Orthopedics
Pediatrics
Pediatrics - methods
Radiology
Review Article
Tomography
Tomography, Emission-Computed, Single-Photon
Tomography, X-Ray Computed
Wounds and Injuries - diagnostic imaging
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hybrid SPECT/CT imaging is becoming the standard of care in pediatric imaging. Indications are mainly for oncologic imaging including mIBG scintigraphy for neuroblastoma and I-123 post surgical imaging of children with thyroid carcinoma, bone scintigraphy for back pain, children referred from sports medicine and neurodevelopmentally delayed children presenting with pain symptoms. The studies provide improved diagnostic accuracy, and oncologic imaging that includes optimized CT as part of the SPECT/CT study may decrease the number of studies and sedation procedures an individual child may need. The studies, however, must be tailored on an individual basis as the addition of the CT study can increase exposure to the child and should only be performed after appropriate justification and with adherence to optimized low dose pediatric protocols.
ISSN:1619-7070
1619-7089
DOI:10.1007/s00259-014-2697-7